Found: 14
Select item for more details and to access through your institution.
Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 4, p. 521, doi. 10.1007/s40257-023-00774-8
- By:
- Publication type:
- Article
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0425-4
- By:
- Publication type:
- Article
Grzybowski's Generalized Eruptive Keratoacanthomas in a Patient with Terminal Kidney Disease—An Unmet Medical Need Equally Ameliorated by Topical Imiquimod Cream and Lapacho Tea Wraps: A Case Report.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 2, p. 625, doi. 10.1007/s13555-021-00502-2
- By:
- Publication type:
- Article
CTLA4 DNA methylation is associated with CTLA-4 expression and predicts response to immunotherapy in head and neck squamous cell carcinoma.
- Published in:
- Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01525-6
- By:
- Publication type:
- Article
DNA methylation regulates TIGIT expression within the melanoma microenvironment, is prognostic for overall survival, and predicts progression-free survival in patients treated with anti-PD-1 immunotherapy.
- Published in:
- Clinical Epigenetics, 2022, v. 14, n. 1, p. 1, doi. 10.1186/s13148-022-01270-2
- By:
- Publication type:
- Article
ICOS DNA methylation regulates melanoma cell-intrinsic ICOS expression, is associated with melanoma differentiation, prognosis, and predicts response to immune checkpoint blockade.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00508-2
- By:
- Publication type:
- Article
Annular plaques mimicking Rowell's syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?
- Published in:
- Journal of Dermatology, 2022, v. 49, n. 1, p. 151, doi. 10.1111/1346-8138.16210
- By:
- Publication type:
- Article
Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
- Published in:
- Clinical Chemistry, 2024, v. 70, n. 3, p. 516, doi. 10.1093/clinchem/hvad230
- By:
- Publication type:
- Article
Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
- Published in:
- Clinical Chemistry, 2023, v. 69, n. 9, p. 1050, doi. 10.1093/clinchem/hvad084
- By:
- Publication type:
- Article
Cell-Free SHOX2 DNA Methylation in Blood as a Molecular Staging Parameter for Risk Stratification in Renal Cell Carcinoma Patients: A Prospective Observational Cohort Study.
- Published in:
- Clinical Chemistry, 2019, v. 65, n. 4, p. 559, doi. 10.1373/clinchem.2018.297549
- By:
- Publication type:
- Article
Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
- Published in:
- Clinical Chemistry, 2017, v. 63, n. 7, p. 1288, doi. 10.1373/clinchem.2016.270207
- By:
- Publication type:
- Article
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0752-8
- By:
- Publication type:
- Article
Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1342845
- By:
- Publication type:
- Article
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2024, v. 37, n. 2, p. 309, doi. 10.1111/pcmr.13151
- By:
- Publication type:
- Article